Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px
Organisation › Details

Neopharm Group (IL)

Established 1941, Neopharm Group is Israel's leading provider of innovative integrated solutions across the pharmaceutical, medical and healthcare markets with turnover in excess of US$350 million and about 580 employees. Neopharm is positioned as the partner-of-choice and one-stop-shop for multinational biopharmaceutical and medical corporations seeking to enter or expand their business in the Israeli healthcare market. *


Period Start 1941-01-01 established
  Group Neopharm (IL) (Group)
Products Industry pharmaceutical
  Industry 2 biopharmaceutical
  Street 6 Hashiloach Street
  City 49170 Petach Tikva
  Tel +972-3-937-3783
    Address record changed: 2018-07-24
Basic data Employees E: 501 to 1,000 (2013-06-28)
  Currency USD
  Annual sales 350,000,000 (turnover 2012-12-31)
    * Document for �About Section�: Fresenius SE & Co. KGaA. (6/28/13). "Press Release: Fresenius Sells Biotechnology Business". Bad Homburg v. d. H..
Record changed: 2017-04-01


Picture Sacura Get Your Substance to Market iito 600x60px

More documents for Neopharm (IL) (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture Berlin Partner HealthCapital RegMed Forum 2018 October iito 600x60px

» top